Core Laboratories Inc.
CLB
$11.18
$0.211.91%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -102.08% | -36.97% | 30.04% | 180.50% | 46.43% |
| Total Depreciation and Amortization | 1.45% | -0.33% | -2.49% | -1.90% | -0.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,529.17% | 89.78% | 69.64% | -155.58% | 63.21% |
| Change in Net Operating Assets | -119.00% | 1,159.23% | -110.18% | 190.91% | -219.94% |
| Cash from Operations | -67.69% | 57.40% | -23.61% | 210.05% | -71.54% |
| Capital Expenditure | 18.31% | -60.53% | 4.78% | 6.09% | -11.55% |
| Sale of Property, Plant, and Equipment | 53.37% | 503.01% | -36.06% | -64.92% | 812.31% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15,505.00% | -99.05% | 6.80% | 145.76% | 256.44% |
| Cash from Investing | 121.69% | -624.85% | 28.53% | 58.54% | 32.26% |
| Total Debt Issued | 116.67% | -62.50% | 100.00% | -42.86% | 16.67% |
| Total Debt Repaid | 25.00% | 16.67% | -14.29% | -23.53% | 37.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 58.77% | -2,402.04% | -20.99% | -268.18% | 97.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | 0.21% | -0.43% | -0.21% |
| Other Financing Activities | -- | 100.00% | -260.00% | 92.08% | 53.75% |
| Cash from Financing | 76.86% | -119.47% | 35.46% | -235.22% | 77.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 227.32% | -161.31% | 35.84% | 1,443.96% | 86.16% |